Anna Renglin Lindh

Anna Renglin Lindh currently serves as Verksamhetschef Patologi Norden at Unilabs since February 2025. Prior to this role, Anna worked as a Senior Business Consultant at PlantVision AB, assisting life science companies with management strategies. Anna has held several key positions, including Chief Operating Officer at Atlas Antibodies, General Manager and Corporate Director of Operations Development at Recipharm, and Director of Production & Process Development at Janssen Inc., where responsibilities included overseeing vaccine manufacturing operations. Anna's extensive experience also includes roles at Crucell in various leadership capacities within vaccine development and manufacturing. With a PhD in Molecular Genetics from Stockholm University and a background in R&D at DSM Anti-infectives, Anna has a strong foundation in both scientific research and operational management in the life sciences sector.